The share of the life science company Bayer is one of the strongest stocks in the DAX® today. After a US judge recently warned Bayer to make progress in the settlement negotiations, there now seems to be movement in a revised glyphosate settlement. According to reports, details will be agreed in the coming weeks. The billion-dollar lawsuits over the herbicide glyphosate hangs like a sword of Damocles over the stock.
Chart technical outlook:
Please note the important information and the disclaimer.
This information does not constitute investment advice, but advertising. The public offer is made exclusively on the basis of a securities prospectus approved by the Federal Financial Supervisory Authority (“BaFin”). Approval of the prospectus should not be understood as a recommendation to acquire these UniCredit Bank AG securities. Only the prospectus including any supplements is relevant and the Final Terms. It is recommended that you read these documents carefully before making any investment decision in order to fully understand the potential risks and opportunities when making an investment decision. You are about to acquire a product that is not easy and can be difficult to understand.
How the HVB products work
The contribution Bayer – Possible agreement spurs! first appeared on onemarkets blog (HypoVereinsbank – UniCredit Bank AG).
Author: Richard Pfadenhauer
Note: PERSONAL-FINANCIAL.COM publishes analyzes, columns and news from various sources in this section. PERSONAL-FINANCIAL.COM AG is not responsible for content that is recognizable as being posted by third parties in the “News” area of this website and does not adopt it as its own. This content can be identified in particular by a corresponding “from” label below the article heading and / or by the link “To read the full article, please click here.”; The named third party is solely responsible for this content.